Loading Events

« All Events

  • This event has passed.

Covid 19 Vaccines and Treatments: Making Sense of it All

February 10, 2021 @ 7:00 pm 9:00 pm

Presented by Mount Olive Resident,Sean O’Connell, PhD

Please join our presentation on COVID 19 vaccines, how they work, eligibility, availability, side effects and more.  Sean O’Connell, PhD, who is a seasoned healthcare professional with 35 years in immunology, cell biology, regenerative medicine and tissue repair, will present and answer questions.  This event is sponsored by the Mount Olive Democrats and is open to everyone. 

ABOUT DR. SEAN O’CONNELL

Dr. O’Connell is a seasoned healthcare professional with 35 years experience in immunology, cell biology, regenerative medicine and tissue repair. As Founder and President of OConnell Consultants, LLC, Dr. O’Connell has served as interim management or strategic consultant to numerous venture capital, pharmaceutical, biotechnology, medical device and tissue processing companies focusing on operations, pre-clinical and clinical development, commercial opportunity assessment, product and market development strategy. OCC clients have spanned early-stage start-up through large-cap companies. Dr. O’Connell is Chief Scientist in Aegle Research/ICIG, an international catalyst partnership commercializing immune cell therapies (cancer), regenerative medicine therapies, medical inventions, and healthcare centers. Previously Dr. O’Connell has served as Chief Science Officer for Vertical Spine, LLC and as Chief Medical Officer for Cascade Medical Enterprises, LLC. As Director, Medical Affairs for the Transplantation/Tissue Engineering/Immunology Business Unit of Novartis Pharmaceuticals, Dr. O’Connell was responsible for pre-clinical and clinical development, publications and professional relations. Dr. O’Connell was SVP, Medical Direction, for Integrated Communications Corp. (ICC/IPG) and was COO and Co-Founder of Heartland BioTechnologies, LLC, a drug discovery start-up. Dr. O’Connell received his PhD in cancer immunology and molecular biology from Rutgers University and the University of Medicine and Dentistry of New Jersey at New Brunswick (now Rutgers Medical school). Additional post-graduate work includes post-doctoral fellowships at the Department of Toxicology, Rutgers University and the Center for Advanced Biotechnology and Medicine. Dr. O’Connell served as an Assistant Professor in the Department of Surgery, R. W. Johnson Medical School in New Brunswick where he was Head of the Surgical Oncology and Flow Cytometry & Immunology Laboratories. Dr. O’Connell received research grants from the New Jersey Cancer Commission, Sandoz/Novartis Pharmaceuticals and American Home Products involving studies in wound healing, host response to biomaterials, solid tumor-host immune response and graft versus host disease. Dr. O’Connell has authored over 65 peer-reviewed publications and abstracts and currently holds the position of Adjunct Professor in the Department of Vascular Surgery, Englewood Hospital and Medical Center, Mount Sinai School of Medicine, New York.



PRESENTATION OUTLINE

  • Q1- What are the COVID-19 Vaccines?
    • Currently available vaccines in the US (Emergency Use Authorization)
    • Vaccines coming soon (Phase 3 development)
  • Q2- What, exactly, are these Vaccines?
    • Vaccine types
    • How do they work?
    • How do they differ from more conventional vaccines like those for the flu and MMR
  • Q3- Vaccine Distribution/Roll Out
    • Who is currently eligible to receive the vaccine?
      • § Phases 1a, 1b, 1c, 2
      • § Recent changes to eligibility
    • What is the current status of the vaccine roll out?
    • Vaccine availability?
  • Q4- What if I have, or have had, COVID, should I still get vaccinated?
  • Q5- Do I still need to wear a mask, practice social-distancing, etc., after I receive the vaccine?
  • Q6- Vaccine Side Effects and Adverse Reactions
    • How were the vaccines tested for safety?
    • What has been reported since EUA approval for Pfizer and Moderna Vaccines? Allergic
    • Allergic/Anaphylactic Reactions – Who is ‘at risk’? How can you prepare?